MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...
Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...
Rust Academy on MSN
Takeover raid: conquering an entire clan base grid
Dive into intense multiplayer action with **“Takeover Raid: Conquering An Entire Clan Base Grid.”** In this video, we showcase a high-stakes raid where an entire clan’s base grid is taken over, ...
Buy Power Grid Corporation of India; target of Rs 324: Prabhudas Lilladher Feb 04 2026 12:35 PM Power Grid shares jump 8% after firm raises FY26 capex guidance to Rs 32,000 crore Feb 02 2026 03:37 PM ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results